The effect of birch pollen immunotherapy on hazelnut allergy.

The effect of birch pollen immunotherapy on hazelnut allergy evaluated by DBPCFC with hazelnut.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON26371

Enrollment

Registered

2005-08-31

Start date

2004-04-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with birch pollen allergy and related hazelnut allergy.

Interventions

Immunotherapy with birch pollen extract .

Eligibility

Inclusion criteria

Inclusion criteria: Patients >18 years with birch pollen allergy and hazelnut allergy.

Exclusion criteria

Exclusion criteria: 1. Pregnancy; 2. significant concurrent disease; 3. instable asthma; 4. oral medication with corticosteroids or b-blocking agents.

Design outcomes

Primary

Measure	Time frame
DBPCFC with hazelnut before immunotherapy with birch pollen and after 1 year.	—

Secondary

Measure	Time frame
Skin prick tests and serological analyses.	—

Contacts

Public ContactK.A.B.M. Peeters

University Medical Center Utrecht (UMCU), Department of Dermatology/Allergology, P.O. box 85500

K.A.B.M.Peeters@umcutrecht.nl+31 (0)30 2507388

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)